North America accounted for the highest share in the global orthopedic navigation system market by region. Besides, factors including the rising elderly population, high healthcare spending by the government, a well-established system of reimbursement, and the presence of reputable manufacturers in the region all support the expansion of the regional market.
New Delhi, Sept. 17, 2022 (GLOBE NEWSWIRE) — Global Orthopedic Navigation System Market size is expanding at a robust double-digit growth rate during the forecast period, mainly due to the orthopedic navigation system’s innovativeness, aging world population, increasing number of joint reconstruction cases, rising healthcare costs, and high patient and healthcare professional awareness levels.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Orthopedic Navigation System Market size at USD 1.87 billion in 2021. And BlueWeave forecasts Global Orthopedic Navigation System Market to grow at an impressive CAGR of 18.2% between 2022 and 2028 to reach a market size of USD 5.75 billion by 2028. Major growth factors for the Global Orthopedic Navigation System Market include an increasing demand for orthopedic therapies, surgeries including joint reconstruction, and solutions driven by the rapidly aging global population.
Global Orthopedic Navigation System Market – Technology Advancements
In the recent past, pedicle screw insertion efficiency was improved by using orthopedic navigation systems during orthopedic spinal surgery. Since then, it has grown in popularity among orthopedic surgeons and has emerged as a crucial tool for several orthopedic procedures, including spine, tumor, sports injury, reconstructive hip, and knee surgery. Orthopedic navigation systems are now made to provide surgeons with in-the-moment input on the operating field, allowing them to modify their surgical technique to enhance postoperative results and reduce intraoperative errors. Additionally, typical and conventional methods may not be accurate, precise, or repeatable. As a result, there is a greater need for the creation of an innovative orthopedic navigation system. This, in turn, is expected to accelerate the rate of expansion of the global orthopedic navigation system market.
Request for Sample Report @ https://www.blueweaveconsulting.com/report/orthopedic-navigation-system-market/report-sample
Global Orthopedic Navigation System Market – Rising Demand
Global orthopedic navigation system market is predicted to boom as a result of an aging population and an increase in joint reconstruction cases, rising healthcare costs, and high patient and healthcare professional awareness levels. Orthopedic disorders including osteoporosis, osteoarthritis, rheumatoid arthritis, and ligamentous knee injuries are becoming more common. The musculoskeletal system of the body, which consists of muscles, bones, joints, nerves, ligaments, cartilage, and tendons, is impacted by these diseases. Reduced range of motion, stiffness, edema, and muscle pain follow, is necessitating subsequent surgical intervention. In the coming years, it is projected that it would increase demand for orthopedic navigation systems. The CDC estimates that 54.4 million Americans (or 1 in 4) have some kind of arthritis, and that number is anticipated to rise to 78 million by the year 2040. It suggests that the adoption of navigation systems for orthopedic procedures would increase further in the near future.
Segmental Coverage
Global Orthopedic Navigation System – By Application
The knee segment dominated the total market in 2021 and will continue to grow at a consistent CAGR over the coming years. The reasons for its dominance include an increase in total knee replacement surgeries and public knowledge of the benefits they provide. Further supporting factors for the segment growth include expanding uses in a variety of surgical circumstances, including revision knee replacement, patellofemoral arthroplasty, unicompartmental (partial) knee replacement, and total knee arthroplasty. The number of knee surgery procedures is projected to increase as a result of rising technological developments, such as minimally invasive procedures, together with the accessibility of enhanced implant materials, which will encourage segment expansion.
The spine segment, on the other hand, is projected to record growth at the fastest CAGR between 2022 and 2028. The prevalence of spinal problems is rising, which has led to an increase in the number of spine procedures. The main cause of death and morbidity due to spinal injuries is either neurological injury weakness or bony spine damage to the spinal nerves or spinal cord. To reduce persistent functional impairment, quick medical and surgical intervention is essential. Additionally, the incidence of sports injuries is rising, along with the number of falls and traffic accidents.
Please Visit the Press Release: https://www.blueweaveconsulting.com/press-release/global-orthopedic-navigation-system-market-surging-to-triple-its-size-touching-usd-5-75-billion-by-2028
Regional Insights
Due to the availability of better infrastructure, high awareness levels, and supportive government initiatives relevant to the promotion of orthopedic navigation systems, North America accounted for the highest revenue share. Besides, factors including the rising elderly population, high healthcare spending by the government, a well-established system of reimbursement, and the presence of reputable manufacturers in the region all support the expansion of the regional market. Due to the high number of unmet clinical needs, the rise in government initiatives to increase patient awareness of minimally invasive procedures for replacement surgeries, and rising investments by manufacturers for the creation of affordable orthopedic navigation systems, Asia Pacific (APAC) is expected to record growth at the fastest rate from 2022 to 2028. As older people are more likely to develop orthopedic illnesses, APAC as a whole offers a sizable target market, with Japan, China, and India being the main regional contributors.
Impact of COVID-19 on Global Orthopedic Navigation System Market
Numerous industries have been disrupted by the 2019 coronavirus illness (COVID-19), which had also resulted in trade and supply chain constraints on a global scale. Many cases of this contagious illness, which ranges in severity from extremely mild to life-threatening, have been reported as a result of the COVID-19 pandemic. Outpatient visits to healthcare providers have reduced due to worries about contracting the virus. Patients are occasionally needed to present with negative COVID-19 test results even in the absence of symptoms before undergoing specific surgical procedures.
During lockdowns, hospitals might not have enough supplies to handle an unexpected patient inflow, forcing them to cancel elective treatments and rearrange ICU beds. Also, a number of procedures were postponed or canceled to protect the wellbeing of patients and personnel due to the high risk of infectious transmission among patients and healthcare professionals. However, to effectively handle these difficulties, carry out time-efficient surgery over long operative hours, and reduce the transmission of infectious diseases, the usage of surgical robots has expanded. The hospital business is anticipated to see an increase in cases that were delayed or postponed due to the pandemic as the pandemic is currently reaching its end in most nations. During the period in analysis, this is most likely to fuel the market for orthopedic navigation systems.
Don’t miss the business opportunity in the Global Orthopedic Navigation System Market. Consult our analysts to gain crucial insights and facilitate your business growth.
Competitive Landscape
To increase their market penetration, the leading companies engage in a variety of activities, including the development of new products, distribution agreements, and growth plans. For instance, Stryker finalized the acquisition of Wright Medical in November 2020 in an effort to strengthen its position in the worldwide trauma and extremities market, offering considerable prospects to better results, accelerate innovation, and broaden patient access.
Smith+Nephew launched the RI.HIP Navigation for Total Hip Arthroplasty in July 2020. (THA). The FDA of the United States granted 510(k) approval for this product, and the CE Mark was certified for THA. These activities are expected to increase the level of competition in the market in the upcoming years. Leading companies in the global orthopedic navigation systems market include AG B. Braun Melsungen, Stryker, and Medtronic.
Recent Developments
In November 2020, Stryker completed the acquisition of Wright Medical, a US-based global medical device company with expertise in extremities and biologics, to strengthen its position in the global trauma and extremities market. The acquisition of Wright Medical is expected to enable Stryker to accelerate innovations and broaden patient access.
Scope of the Report
Attributes
Details
Years Considered
Historical Data – 2018–2021
Base Year – 2021
Estimated Year – 2022
Forecast – 2022–2028
Facts Covered
Revenues in USD Million
Market Coverage
North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Product Service/Segmentation
By Technology, By Practice, By End User, By Region
Key Players
B. Braun Melsungen AG, Stryker, Medtronic, Johnson & Johnson, Smith & Nephew Plc, Zimmer Biomet, Amplitude Surgical, Kinamed Inc., Globus Medical, Orth Align
By Technology
Electromagnetic
Optical
By Application
Knee
Hip
Spine
By End User
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Please Find Below Some New Reports:
Artificial Cornea and Corneal Implant Market -Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028
Clinical Chemistry Analyzers Market- Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028
Urinary Catheters Market – Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028
Peptide and Anticoagulant Drugs Market- Global Industry Size, Share, Trend Analysis and Forecast Report, 2018-2028
Point of Care (PoC) Infectious Disease Testing Market – Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018–2028
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BWC has built its reputation from scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
info@blueweaveconsulting.com
https://www.blueweaveconsulting.com/
https://www.linkedin.com/company/blueweaveconsulting/
(Bloomberg) — John Paulson became a billionaire after his hedge fund effectively shorted more than $25 billion of mortgage securities at the dawn of the global financial crisis. Most Read from BloombergBank of England Says Paper Banknotes Only Good for One More WeekThe Great Bond Bubble Is ‘Poof, Gone’ in Worst Year Since 1949‘Read Putin More Often and Carefully,’ Lavrov Tells the WorldUK Market Plunge Sparks Talk of Emergency BOE Rate HikeAs he sizes up yet another frothy housing market some 1
The first half of the year saw the benchmark S&P 500 (SNPINDEX: ^GSPC) produce its worst return since 1970. With the S&P 500 and Nasdaq respectively declining 24% and 34%, respectively, at their peaks, both indexes have firmly entered bear market territory. Given the heightened volatility and uncertainty that accompanies bear markets, it has a lot of investors wondering where the market will bottom.
It is the worst year for buying the stock-market dip since the 1930s. Instead of rebounding after a tumble, stocks have continued to fall, denting a strategy that soared in popularity over the past decade.
Cathie Wood's Ark Innovation ETF, which focuses on such stocks, has plunged by nearly 75% from its early 2021 peak, and some individual companies have fallen further. Advanced Micro Devices (NASDAQ: AMD), Meta Platforms (NASDAQ: META), and Twilio (NYSE: TWLO) are likely three such stocks. Jake Lerch (Advanced Micro Devices): There's plenty of carnage in the stock market among tech stocks, and AMD is no exception.
KEY WORDS “I think we’re giving Powell too much praise. … The last two years are one of the biggest policy mistakes in the 110-year history of the Fed by staying so easy when everything was booming.
Stocks have taken a bumpy ride this year. The S&P 500 was in a free fall for the first six months of 2022, tumbling about 24% from peak to trough on fears that rising interest rates to combat inflation could cause a recession. With the market growing fearful again, our contributors think that some stocks are starting to look like great bargains.
These EV stocks are way down, but that's no guarantee that investors who buy shares now will make money.
These rock-solid income stocks, with yields ranging from 5% to 7%, can pad aged investors' pocketbooks while making them richer.
Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Nvidia Corp. recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings.
AT&T (NYSE: T) and IBM (NYSE: IBM) both underwent dramatic transformations over the past year. AT&T divested DirecTV, merged WarnerMedia with Discovery to create Warner Bros. Discovery (NASDAQ: WBD) , and sold many of its non-core assets to prioritize the growth of its core telecom business.
The S&P 500 could be set for a long period of sideways trading that make the returns of the last decade seem like a dream.
These are the dividend stocks in the Russell 1000 with the highest forward dividend yield for September.
With a price-to-earnings (or "P/E") ratio of 37.6x Alibaba Group Holding Limited ( NYSE:BABA ) may be sending very…
No one knows for sure when the next bull market will start, but we do know one thing: There will be another bull market eventually. While there have been several bear markets during that time, none of them have knocked the U.S. stock market off its growth trajectory. In fact, since the average length of a bear market is only about nine months, the current one, which began in early January when the S&P 500 peaked, has already lasted about as long as a typical bear market.
When it comes to building wealth over time, it's hard to beat a strategy of dollar-cost averaging into a broad index fund.
Trending social-media hashtags aside, the U.S. stock market hasn't crashed — but a volatile bear market is making for queasy investors.
These two stocks have such solid growth potential that you might want to buy them before September ends.
It's a global leader in cybersecurity, a sector I believe is growing increasingly important as digital transformation takes hold, bringing more business processes online and increasing cyber risks. It's now easier to purchase without using fractional shares if you're only investing a few hundred dollars at a time, like me. Cybersecurity companies are reporting staggering rises in attacks.
After years of rapid expansion, the jury is now out on Shopify (NYSE: SHOP) stock. The last I wrote about Shopify following the second-quarter report, I discussed what accounted for the company's massive $2.68 billion net loss (using GAAP, or generally accepted accounting principles) through the first half of 2022. GAAP net income or net loss doesn't really tell the true profitability of Shopify's actual operations.
Federal Reserve officials have a busy week of speeches ahead. Investors are desperate for more information on the future of rates.